Request for Covid-19 Impact Assessment of this Report
The United States Cystic Fibrosis Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Cystic Fibrosis Drugs market, reaching US$ million by the year 2028. As for the Europe Cystic Fibrosis Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Cystic Fibrosis Drugs players cover Actavis, F. Hoffmann-La Roche, Gilead Sciences, and Novartis, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Cystic Fibrosis Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Oral Cystic Fibrosis Drugs
Injection Cystic Fibrosis Drugs
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals
Clinics
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Actavis
F. Hoffmann-La Roche
Gilead Sciences
Novartis
Vertex Pharmaceuticals
Abbott
Anthera Pharmaceuticals
Arcturus Therapeutics
Boehringer Ingelheim
Chiesi Farmaceutici
Corbus Pharmaceuticals
Genzyme
Insmed
Johnson & Johnson
Merck Sharp & Dohme
Neovii Biotech
Novo Nordisk
PharmaSwiss
Pharmaxis
Proteostasis Therapeutics
PTC Therapeutics
United Medical
Venus Remedies
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cystic Fibrosis Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Cystic Fibrosis Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Cystic Fibrosis Drugs by Country/Region, 2017, 2022 & 2028
2.2 Cystic Fibrosis Drugs Segment by Type
2.2.1 Oral Cystic Fibrosis Drugs
2.2.2 Injection Cystic Fibrosis Drugs
2.3 Cystic Fibrosis Drugs Sales by Type
2.3.1 Global Cystic Fibrosis Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Cystic Fibrosis Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Cystic Fibrosis Drugs Sale Price by Type (2017-2022)
2.4 Cystic Fibrosis Drugs Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Other
2.5 Cystic Fibrosis Drugs Sales by Application
2.5.1 Global Cystic Fibrosis Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Cystic Fibrosis Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Cystic Fibrosis Drugs Sale Price by Application (2017-2022)
3 Global Cystic Fibrosis Drugs by Company
3.1 Global Cystic Fibrosis Drugs Breakdown Data by Company
3.1.1 Global Cystic Fibrosis Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Cystic Fibrosis Drugs Sales Market Share by Company (2020-2022)
3.2 Global Cystic Fibrosis Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Cystic Fibrosis Drugs Revenue by Company (2020-2022)
3.2.2 Global Cystic Fibrosis Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Cystic Fibrosis Drugs Sale Price by Company
3.4 Key Manufacturers Cystic Fibrosis Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cystic Fibrosis Drugs Product Location Distribution
3.4.2 Players Cystic Fibrosis Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Cystic Fibrosis Drugs by Geographic Region
4.1 World Historic Cystic Fibrosis Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Cystic Fibrosis Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Cystic Fibrosis Drugs Annual Revenue by Geographic Region
4.2 World Historic Cystic Fibrosis Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Cystic Fibrosis Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Cystic Fibrosis Drugs Annual Revenue by Country/Region
4.3 Americas Cystic Fibrosis Drugs Sales Growth
4.4 APAC Cystic Fibrosis Drugs Sales Growth
4.5 Europe Cystic Fibrosis Drugs Sales Growth
4.6 Middle East & Africa Cystic Fibrosis Drugs Sales Growth
5 Americas
5.1 Americas Cystic Fibrosis Drugs Sales by Country
5.1.1 Americas Cystic Fibrosis Drugs Sales by Country (2017-2022)
5.1.2 Americas Cystic Fibrosis Drugs Revenue by Country (2017-2022)
5.2 Americas Cystic Fibrosis Drugs Sales by Type
5.3 Americas Cystic Fibrosis Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cystic Fibrosis Drugs Sales by Region
6.1.1 APAC Cystic Fibrosis Drugs Sales by Region (2017-2022)
6.1.2 APAC Cystic Fibrosis Drugs Revenue by Region (2017-2022)
6.2 APAC Cystic Fibrosis Drugs Sales by Type
6.3 APAC Cystic Fibrosis Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Cystic Fibrosis Drugs by Country
7.1.1 Europe Cystic Fibrosis Drugs Sales by Country (2017-2022)
7.1.2 Europe Cystic Fibrosis Drugs Revenue by Country (2017-2022)
7.2 Europe Cystic Fibrosis Drugs Sales by Type
7.3 Europe Cystic Fibrosis Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cystic Fibrosis Drugs by Country
8.1.1 Middle East & Africa Cystic Fibrosis Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Cystic Fibrosis Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Cystic Fibrosis Drugs Sales by Type
8.3 Middle East & Africa Cystic Fibrosis Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cystic Fibrosis Drugs
10.3 Manufacturing Process Analysis of Cystic Fibrosis Drugs
10.4 Industry Chain Structure of Cystic Fibrosis Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cystic Fibrosis Drugs Distributors
11.3 Cystic Fibrosis Drugs Customer
12 World Forecast Review for Cystic Fibrosis Drugs by Geographic Region
12.1 Global Cystic Fibrosis Drugs Market Size Forecast by Region
12.1.1 Global Cystic Fibrosis Drugs Forecast by Region (2023-2028)
12.1.2 Global Cystic Fibrosis Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Cystic Fibrosis Drugs Forecast by Type
12.7 Global Cystic Fibrosis Drugs Forecast by Application
13 Key Players Analysis
13.1 Actavis
13.1.1 Actavis Company Information
13.1.2 Actavis Cystic Fibrosis Drugs Product Offered
13.1.3 Actavis Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Actavis Main Business Overview
13.1.5 Actavis Latest Developments
13.2 F. Hoffmann-La Roche
13.2.1 F. Hoffmann-La Roche Company Information
13.2.2 F. Hoffmann-La Roche Cystic Fibrosis Drugs Product Offered
13.2.3 F. Hoffmann-La Roche Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 F. Hoffmann-La Roche Main Business Overview
13.2.5 F. Hoffmann-La Roche Latest Developments
13.3 Gilead Sciences
13.3.1 Gilead Sciences Company Information
13.3.2 Gilead Sciences Cystic Fibrosis Drugs Product Offered
13.3.3 Gilead Sciences Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Gilead Sciences Main Business Overview
13.3.5 Gilead Sciences Latest Developments
13.4 Novartis
13.4.1 Novartis Company Information
13.4.2 Novartis Cystic Fibrosis Drugs Product Offered
13.4.3 Novartis Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Novartis Main Business Overview
13.4.5 Novartis Latest Developments
13.5 Vertex Pharmaceuticals
13.5.1 Vertex Pharmaceuticals Company Information
13.5.2 Vertex Pharmaceuticals Cystic Fibrosis Drugs Product Offered
13.5.3 Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Vertex Pharmaceuticals Main Business Overview
13.5.5 Vertex Pharmaceuticals Latest Developments
13.6 Abbott
13.6.1 Abbott Company Information
13.6.2 Abbott Cystic Fibrosis Drugs Product Offered
13.6.3 Abbott Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Abbott Main Business Overview
13.6.5 Abbott Latest Developments
13.7 Anthera Pharmaceuticals
13.7.1 Anthera Pharmaceuticals Company Information
13.7.2 Anthera Pharmaceuticals Cystic Fibrosis Drugs Product Offered
13.7.3 Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Anthera Pharmaceuticals Main Business Overview
13.7.5 Anthera Pharmaceuticals Latest Developments
13.8 Arcturus Therapeutics
13.8.1 Arcturus Therapeutics Company Information
13.8.2 Arcturus Therapeutics Cystic Fibrosis Drugs Product Offered
13.8.3 Arcturus Therapeutics Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Arcturus Therapeutics Main Business Overview
13.8.5 Arcturus Therapeutics Latest Developments
13.9 Boehringer Ingelheim
13.9.1 Boehringer Ingelheim Company Information
13.9.2 Boehringer Ingelheim Cystic Fibrosis Drugs Product Offered
13.9.3 Boehringer Ingelheim Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Boehringer Ingelheim Main Business Overview
13.9.5 Boehringer Ingelheim Latest Developments
13.10 Chiesi Farmaceutici
13.10.1 Chiesi Farmaceutici Company Information
13.10.2 Chiesi Farmaceutici Cystic Fibrosis Drugs Product Offered
13.10.3 Chiesi Farmaceutici Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Chiesi Farmaceutici Main Business Overview
13.10.5 Chiesi Farmaceutici Latest Developments
13.11 Corbus Pharmaceuticals
13.11.1 Corbus Pharmaceuticals Company Information
13.11.2 Corbus Pharmaceuticals Cystic Fibrosis Drugs Product Offered
13.11.3 Corbus Pharmaceuticals Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Corbus Pharmaceuticals Main Business Overview
13.11.5 Corbus Pharmaceuticals Latest Developments
13.12 Genzyme
13.12.1 Genzyme Company Information
13.12.2 Genzyme Cystic Fibrosis Drugs Product Offered
13.12.3 Genzyme Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Genzyme Main Business Overview
13.12.5 Genzyme Latest Developments
13.13 Insmed
13.13.1 Insmed Company Information
13.13.2 Insmed Cystic Fibrosis Drugs Product Offered
13.13.3 Insmed Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Insmed Main Business Overview
13.13.5 Insmed Latest Developments
13.14 Johnson & Johnson
13.14.1 Johnson & Johnson Company Information
13.14.2 Johnson & Johnson Cystic Fibrosis Drugs Product Offered
13.14.3 Johnson & Johnson Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Johnson & Johnson Main Business Overview
13.14.5 Johnson & Johnson Latest Developments
13.15 Merck Sharp & Dohme
13.15.1 Merck Sharp & Dohme Company Information
13.15.2 Merck Sharp & Dohme Cystic Fibrosis Drugs Product Offered
13.15.3 Merck Sharp & Dohme Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Merck Sharp & Dohme Main Business Overview
13.15.5 Merck Sharp & Dohme Latest Developments
13.16 Neovii Biotech
13.16.1 Neovii Biotech Company Information
13.16.2 Neovii Biotech Cystic Fibrosis Drugs Product Offered
13.16.3 Neovii Biotech Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Neovii Biotech Main Business Overview
13.16.5 Neovii Biotech Latest Developments
13.17 Novo Nordisk
13.17.1 Novo Nordisk Company Information
13.17.2 Novo Nordisk Cystic Fibrosis Drugs Product Offered
13.17.3 Novo Nordisk Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Novo Nordisk Main Business Overview
13.17.5 Novo Nordisk Latest Developments
13.18 PharmaSwiss
13.18.1 PharmaSwiss Company Information
13.18.2 PharmaSwiss Cystic Fibrosis Drugs Product Offered
13.18.3 PharmaSwiss Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 PharmaSwiss Main Business Overview
13.18.5 PharmaSwiss Latest Developments
13.19 Pharmaxis
13.19.1 Pharmaxis Company Information
13.19.2 Pharmaxis Cystic Fibrosis Drugs Product Offered
13.19.3 Pharmaxis Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Pharmaxis Main Business Overview
13.19.5 Pharmaxis Latest Developments
13.20 Proteostasis Therapeutics
13.20.1 Proteostasis Therapeutics Company Information
13.20.2 Proteostasis Therapeutics Cystic Fibrosis Drugs Product Offered
13.20.3 Proteostasis Therapeutics Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Proteostasis Therapeutics Main Business Overview
13.20.5 Proteostasis Therapeutics Latest Developments
13.21 PTC Therapeutics
13.21.1 PTC Therapeutics Company Information
13.21.2 PTC Therapeutics Cystic Fibrosis Drugs Product Offered
13.21.3 PTC Therapeutics Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.21.4 PTC Therapeutics Main Business Overview
13.21.5 PTC Therapeutics Latest Developments
13.22 United Medical
13.22.1 United Medical Company Information
13.22.2 United Medical Cystic Fibrosis Drugs Product Offered
13.22.3 United Medical Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.22.4 United Medical Main Business Overview
13.22.5 United Medical Latest Developments
13.23 Venus Remedies
13.23.1 Venus Remedies Company Information
13.23.2 Venus Remedies Cystic Fibrosis Drugs Product Offered
13.23.3 Venus Remedies Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.23.4 Venus Remedies Main Business Overview
13.23.5 Venus Remedies Latest Developments
14 Research Findings and Conclusion
Table 1. Cystic Fibrosis Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Cystic Fibrosis Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Oral Cystic Fibrosis Drugs
Table 4. Major Players of Injection Cystic Fibrosis Drugs
Table 5. Global Cystic Fibrosis Drugs Sales by Type (2017-2022) & (K Pcs)
Table 6. Global Cystic Fibrosis Drugs Sales Market Share by Type (2017-2022)
Table 7. Global Cystic Fibrosis Drugs Revenue by Type (2017-2022) & ($ million)
Table 8. Global Cystic Fibrosis Drugs Revenue Market Share by Type (2017-2022)
Table 9. Global Cystic Fibrosis Drugs Sale Price by Type (2017-2022) & (USD/Pcs)
Table 10. Global Cystic Fibrosis Drugs Sales by Application (2017-2022) & (K Pcs)
Table 11. Global Cystic Fibrosis Drugs Sales Market Share by Application (2017-2022)
Table 12. Global Cystic Fibrosis Drugs Revenue by Application (2017-2022)
Table 13. Global Cystic Fibrosis Drugs Revenue Market Share by Application (2017-2022)
Table 14. Global Cystic Fibrosis Drugs Sale Price by Application (2017-2022) & (USD/Pcs)
Table 15. Global Cystic Fibrosis Drugs Sales by Company (2020-2022) & (K Pcs)
Table 16. Global Cystic Fibrosis Drugs Sales Market Share by Company (2020-2022)
Table 17. Global Cystic Fibrosis Drugs Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Cystic Fibrosis Drugs Revenue Market Share by Company (2020-2022)
Table 19. Global Cystic Fibrosis Drugs Sale Price by Company (2020-2022) & (USD/Pcs)
Table 20. Key Manufacturers Cystic Fibrosis Drugs Producing Area Distribution and Sales Area
Table 21. Players Cystic Fibrosis Drugs Products Offered
Table 22. Cystic Fibrosis Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Cystic Fibrosis Drugs Sales by Geographic Region (2017-2022) & (K Pcs)
Table 26. Global Cystic Fibrosis Drugs Sales Market Share Geographic Region (2017-2022)
Table 27. Global Cystic Fibrosis Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Cystic Fibrosis Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Cystic Fibrosis Drugs Sales by Country/Region (2017-2022) & (K Pcs)
Table 30. Global Cystic Fibrosis Drugs Sales Market Share by Country/Region (2017-2022)
Table 31. Global Cystic Fibrosis Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Cystic Fibrosis Drugs Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Cystic Fibrosis Drugs Sales by Country (2017-2022) & (K Pcs)
Table 34. Americas Cystic Fibrosis Drugs Sales Market Share by Country (2017-2022)
Table 35. Americas Cystic Fibrosis Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Cystic Fibrosis Drugs Revenue Market Share by Country (2017-2022)
Table 37. Americas Cystic Fibrosis Drugs Sales by Type (2017-2022) & (K Pcs)
Table 38. Americas Cystic Fibrosis Drugs Sales Market Share by Type (2017-2022)
Table 39. Americas Cystic Fibrosis Drugs Sales by Application (2017-2022) & (K Pcs)
Table 40. Americas Cystic Fibrosis Drugs Sales Market Share by Application (2017-2022)
Table 41. APAC Cystic Fibrosis Drugs Sales by Region (2017-2022) & (K Pcs)
Table 42. APAC Cystic Fibrosis Drugs Sales Market Share by Region (2017-2022)
Table 43. APAC Cystic Fibrosis Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Cystic Fibrosis Drugs Revenue Market Share by Region (2017-2022)
Table 45. APAC Cystic Fibrosis Drugs Sales by Type (2017-2022) & (K Pcs)
Table 46. APAC Cystic Fibrosis Drugs Sales Market Share by Type (2017-2022)
Table 47. APAC Cystic Fibrosis Drugs Sales by Application (2017-2022) & (K Pcs)
Table 48. APAC Cystic Fibrosis Drugs Sales Market Share by Application (2017-2022)
Table 49. Europe Cystic Fibrosis Drugs Sales by Country (2017-2022) & (K Pcs)
Table 50. Europe Cystic Fibrosis Drugs Sales Market Share by Country (2017-2022)
Table 51. Europe Cystic Fibrosis Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Cystic Fibrosis Drugs Revenue Market Share by Country (2017-2022)
Table 53. Europe Cystic Fibrosis Drugs Sales by Type (2017-2022) & (K Pcs)
Table 54. Europe Cystic Fibrosis Drugs Sales Market Share by Type (2017-2022)
Table 55. Europe Cystic Fibrosis Drugs Sales by Application (2017-2022) & (K Pcs)
Table 56. Europe Cystic Fibrosis Drugs Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Cystic Fibrosis Drugs Sales by Country (2017-2022) & (K Pcs)
Table 58. Middle East & Africa Cystic Fibrosis Drugs Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Cystic Fibrosis Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Cystic Fibrosis Drugs Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Cystic Fibrosis Drugs Sales by Type (2017-2022) & (K Pcs)
Table 62. Middle East & Africa Cystic Fibrosis Drugs Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Cystic Fibrosis Drugs Sales by Application (2017-2022) & (K Pcs)
Table 64. Middle East & Africa Cystic Fibrosis Drugs Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Cystic Fibrosis Drugs
Table 66. Key Market Challenges & Risks of Cystic Fibrosis Drugs
Table 67. Key Industry Trends of Cystic Fibrosis Drugs
Table 68. Cystic Fibrosis Drugs Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Cystic Fibrosis Drugs Distributors List
Table 71. Cystic Fibrosis Drugs Customer List
Table 72. Global Cystic Fibrosis Drugs Sales Forecast by Region (2023-2028) & (K Pcs)
Table 73. Global Cystic Fibrosis Drugs Sales Market Forecast by Region
Table 74. Global Cystic Fibrosis Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Cystic Fibrosis Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Cystic Fibrosis Drugs Sales Forecast by Country (2023-2028) & (K Pcs)
Table 77. Americas Cystic Fibrosis Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Cystic Fibrosis Drugs Sales Forecast by Region (2023-2028) & (K Pcs)
Table 79. APAC Cystic Fibrosis Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Cystic Fibrosis Drugs Sales Forecast by Country (2023-2028) & (K Pcs)
Table 81. Europe Cystic Fibrosis Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Cystic Fibrosis Drugs Sales Forecast by Country (2023-2028) & (K Pcs)
Table 83. Middle East & Africa Cystic Fibrosis Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Cystic Fibrosis Drugs Sales Forecast by Type (2023-2028) & (K Pcs)
Table 85. Global Cystic Fibrosis Drugs Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Cystic Fibrosis Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Cystic Fibrosis Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Cystic Fibrosis Drugs Sales Forecast by Application (2023-2028) & (K Pcs)
Table 89. Global Cystic Fibrosis Drugs Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Cystic Fibrosis Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Cystic Fibrosis Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 92. Actavis Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Actavis Cystic Fibrosis Drugs Product Offered
Table 94. Actavis Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 95. Actavis Main Business
Table 96. Actavis Latest Developments
Table 97. F. Hoffmann-La Roche Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. F. Hoffmann-La Roche Cystic Fibrosis Drugs Product Offered
Table 99. F. Hoffmann-La Roche Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 100. F. Hoffmann-La Roche Main Business
Table 101. F. Hoffmann-La Roche Latest Developments
Table 102. Gilead Sciences Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Gilead Sciences Cystic Fibrosis Drugs Product Offered
Table 104. Gilead Sciences Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 105. Gilead Sciences Main Business
Table 106. Gilead Sciences Latest Developments
Table 107. Novartis Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Novartis Cystic Fibrosis Drugs Product Offered
Table 109. Novartis Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 110. Novartis Main Business
Table 111. Novartis Latest Developments
Table 112. Vertex Pharmaceuticals Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Vertex Pharmaceuticals Cystic Fibrosis Drugs Product Offered
Table 114. Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 115. Vertex Pharmaceuticals Main Business
Table 116. Vertex Pharmaceuticals Latest Developments
Table 117. Abbott Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Abbott Cystic Fibrosis Drugs Product Offered
Table 119. Abbott Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 120. Abbott Main Business
Table 121. Abbott Latest Developments
Table 122. Anthera Pharmaceuticals Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Anthera Pharmaceuticals Cystic Fibrosis Drugs Product Offered
Table 124. Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 125. Anthera Pharmaceuticals Main Business
Table 126. Anthera Pharmaceuticals Latest Developments
Table 127. Arcturus Therapeutics Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Arcturus Therapeutics Cystic Fibrosis Drugs Product Offered
Table 129. Arcturus Therapeutics Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 130. Arcturus Therapeutics Main Business
Table 131. Arcturus Therapeutics Latest Developments
Table 132. Boehringer Ingelheim Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Boehringer Ingelheim Cystic Fibrosis Drugs Product Offered
Table 134. Boehringer Ingelheim Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 135. Boehringer Ingelheim Main Business
Table 136. Boehringer Ingelheim Latest Developments
Table 137. Chiesi Farmaceutici Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 138. Chiesi Farmaceutici Cystic Fibrosis Drugs Product Offered
Table 139. Chiesi Farmaceutici Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 140. Chiesi Farmaceutici Main Business
Table 141. Chiesi Farmaceutici Latest Developments
Table 142. Corbus Pharmaceuticals Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 143. Corbus Pharmaceuticals Cystic Fibrosis Drugs Product Offered
Table 144. Corbus Pharmaceuticals Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 145. Corbus Pharmaceuticals Main Business
Table 146. Corbus Pharmaceuticals Latest Developments
Table 147. Genzyme Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 148. Genzyme Cystic Fibrosis Drugs Product Offered
Table 149. Genzyme Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 150. Genzyme Main Business
Table 151. Genzyme Latest Developments
Table 152. Insmed Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 153. Insmed Cystic Fibrosis Drugs Product Offered
Table 154. Insmed Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 155. Insmed Main Business
Table 156. Insmed Latest Developments
Table 157. Johnson & Johnson Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 158. Johnson & Johnson Cystic Fibrosis Drugs Product Offered
Table 159. Johnson & Johnson Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 160. Johnson & Johnson Main Business
Table 161. Johnson & Johnson Latest Developments
Table 162. Merck Sharp & Dohme Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 163. Merck Sharp & Dohme Cystic Fibrosis Drugs Product Offered
Table 164. Merck Sharp & Dohme Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 165. Merck Sharp & Dohme Main Business
Table 166. Merck Sharp & Dohme Latest Developments
Table 167. Neovii Biotech Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 168. Neovii Biotech Cystic Fibrosis Drugs Product Offered
Table 169. Neovii Biotech Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 170. Neovii Biotech Main Business
Table 171. Neovii Biotech Latest Developments
Table 172. Novo Nordisk Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 173. Novo Nordisk Cystic Fibrosis Drugs Product Offered
Table 174. Novo Nordisk Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 175. Novo Nordisk Main Business
Table 176. Novo Nordisk Latest Developments
Table 177. PharmaSwiss Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 178. PharmaSwiss Cystic Fibrosis Drugs Product Offered
Table 179. PharmaSwiss Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 180. PharmaSwiss Main Business
Table 181. PharmaSwiss Latest Developments
Table 182. Pharmaxis Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 183. Pharmaxis Cystic Fibrosis Drugs Product Offered
Table 184. Pharmaxis Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 185. Pharmaxis Main Business
Table 186. Pharmaxis Latest Developments
Table 187. Proteostasis Therapeutics Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 188. Proteostasis Therapeutics Cystic Fibrosis Drugs Product Offered
Table 189. Proteostasis Therapeutics Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 190. Proteostasis Therapeutics Main Business
Table 191. Proteostasis Therapeutics Latest Developments
Table 192. PTC Therapeutics Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 193. PTC Therapeutics Cystic Fibrosis Drugs Product Offered
Table 194. PTC Therapeutics Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 195. PTC Therapeutics Main Business
Table 196. PTC Therapeutics Latest Developments
Table 197. United Medical Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 198. United Medical Cystic Fibrosis Drugs Product Offered
Table 199. United Medical Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 200. United Medical Main Business
Table 201. United Medical Latest Developments
Table 202. Venus Remedies Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 203. Venus Remedies Cystic Fibrosis Drugs Product Offered
Table 204. Venus Remedies Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 205. Venus Remedies Main Business
Table 206. Venus Remedies Latest Developments
List of Figures
Figure 1. Picture of Cystic Fibrosis Drugs
Figure 2. Cystic Fibrosis Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cystic Fibrosis Drugs Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Cystic Fibrosis Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Cystic Fibrosis Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Oral Cystic Fibrosis Drugs
Figure 10. Product Picture of Injection Cystic Fibrosis Drugs
Figure 11. Global Cystic Fibrosis Drugs Sales Market Share by Type in 2021
Figure 12. Global Cystic Fibrosis Drugs Revenue Market Share by Type (2017-2022)
Figure 13. Cystic Fibrosis Drugs Consumed in Hospitals
Figure 14. Global Cystic Fibrosis Drugs Market: Hospitals (2017-2022) & (K Pcs)
Figure 15. Cystic Fibrosis Drugs Consumed in Clinics
Figure 16. Global Cystic Fibrosis Drugs Market: Clinics (2017-2022) & (K Pcs)
Figure 17. Cystic Fibrosis Drugs Consumed in Other
Figure 18. Global Cystic Fibrosis Drugs Market: Other (2017-2022) & (K Pcs)
Figure 19. Global Cystic Fibrosis Drugs Sales Market Share by Application (2017-2022)
Figure 20. Global Cystic Fibrosis Drugs Revenue Market Share by Application in 2021
Figure 21. Cystic Fibrosis Drugs Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Cystic Fibrosis Drugs Revenue Market Share by Company in 2021
Figure 23. Global Cystic Fibrosis Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Cystic Fibrosis Drugs Revenue Market Share by Geographic Region in 2021
Figure 25. Global Cystic Fibrosis Drugs Sales Market Share by Region (2017-2022)
Figure 26. Global Cystic Fibrosis Drugs Revenue Market Share by Country/Region in 2021
Figure 27. Americas Cystic Fibrosis Drugs Sales 2017-2022 (K Pcs)
Figure 28. Americas Cystic Fibrosis Drugs Revenue 2017-2022 ($ Millions)
Figure 29. APAC Cystic Fibrosis Drugs Sales 2017-2022 (K Pcs)
Figure 30. APAC Cystic Fibrosis Drugs Revenue 2017-2022 ($ Millions)
Figure 31. Europe Cystic Fibrosis Drugs Sales 2017-2022 (K Pcs)
Figure 32. Europe Cystic Fibrosis Drugs Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Cystic Fibrosis Drugs Sales 2017-2022 (K Pcs)
Figure 34. Middle East & Africa Cystic Fibrosis Drugs Revenue 2017-2022 ($ Millions)
Figure 35. Americas Cystic Fibrosis Drugs Sales Market Share by Country in 2021
Figure 36. Americas Cystic Fibrosis Drugs Revenue Market Share by Country in 2021
Figure 37. United States Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Cystic Fibrosis Drugs Sales Market Share by Region in 2021
Figure 42. APAC Cystic Fibrosis Drugs Revenue Market Share by Regions in 2021
Figure 43. China Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Cystic Fibrosis Drugs Sales Market Share by Country in 2021
Figure 50. Europe Cystic Fibrosis Drugs Revenue Market Share by Country in 2021
Figure 51. Germany Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Cystic Fibrosis Drugs Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Cystic Fibrosis Drugs Revenue Market Share by Country in 2021
Figure 58. Egypt Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Cystic Fibrosis Drugs in 2021
Figure 64. Manufacturing Process Analysis of Cystic Fibrosis Drugs
Figure 65. Industry Chain Structure of Cystic Fibrosis Drugs
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...